NCT00271349View on ClinicalTrials.gov

Budesonide for Eosinophilic Esophagitis

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

December 31, 2008

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Budesonide

Trial Locations (1)

4600

Department of Gastroenterology, Kantonsspital, Olten

All Listed Sponsors
lead

Swiss EE Study Group

OTHER

NCT00271349 - Budesonide for Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter